IL6R and multiple sclerosis: Elevated levels of circulating IL-6 and sIL-6R, on the other hand, frequently accompany pathophysiologic conditions and constitute potential drug targets in the treatment of diseases like rheumatoid arthritis, asthma, and multiple sclerosis (3, 12, 17, –, 19).